Domov › Chronická lymfocytová leukémia › Wisconsin › Milwaukee
Klinické štúdie Chronická lymfocytová leukémia v meste Milwaukee, WI
15 štúdií pre Chronická lymfocytová leukémia hľadá účastníkov v zariadeniach v meste Milwaukee a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Prebieha náborFáza 3
- UW Cancer Center at ProHealth Care, Waukesha · 17 míľ odtiaľ
- ProHealth D N Greenwald Center, Mukwonago · 25 míľ odtiaľ
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- a 9 ďalších
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Prebieha náborFáza 3
- Medical College of Wisconsin, Milwaukee
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Prebieha náborFáza 3
- Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Prebieha náborFáza 2
- The Medical College of Wisconsin, Milwaukee
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Prebieha náborFáza 1
- Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Prebieha náborFáza 1
- Medical College of Wisconsin, Milwaukee
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
Prebieha náborFáza 2
- Medical College of Wisconsin, Milwaukee
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Prebieha náborFáza 4
- Medical College of Wisconsin, Milwaukee
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Prebieha náborFáza 4
- Medical College of Wisconsin, Milwaukee
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Prebieha náborFáza 1/2
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Study of SGR-1505 in Mature B-Cell Neoplasms
Prebieha náborFáza 1
- Medical College of Wisconsin, Milwaukee
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Prebieha náborFáza 1
- The Medical College of Wisconsin, Milwaukee
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Prebieha náborObservačná štúdia
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
Prebieha náborObservačná štúdia
- Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee
Štúdie Chronická lymfocytová leukémia v iných mestách
- Boston, MA31 štúdií
- Columbus, OH28 štúdií
- Durham, NC27 štúdií
- Washington, DC22 štúdií
- Seattle, WA20 štúdií
- Rochester, MN18 štúdií
- New York City, NY18 štúdií
- Houston, TX17 štúdií
- Baldwin Park, CA16 štúdií
- Chicago, IL14 štúdií
- Cincinnati, OH14 štúdií
- Nashville, TN13 štúdií
Iné štúdie v Milwaukee
- Rakovina prsníka23 štúdií
- Rakovina (všetky typy)22 štúdií
- Nemalobunkový karcinóm pľúc22 štúdií
- Mnohonásobný myelóm21 štúdií
- Rakovina pľúc21 štúdií
- Rakovina prostaty20 štúdií
- Folikulárny lymfóm19 štúdií
- Non-Hodgkinov lymfóm18 štúdií
- Rakovina pankreasu18 štúdií
- Akútna myeloidná leukémia17 štúdií
- Rakovina vaječníkov17 štúdií
- Difúzny veľkobunkový B-lymfóm16 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.